3 research outputs found
PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy
10.1158/2159-8290.CD-12-0595Cancer Discovery3101156-117
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
10.1038/ncomms9746Nature Communications6874